In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis

被引:22
|
作者
Maria Albani, Clara [1 ,2 ]
Eugenia Pensel, Patricia [1 ,2 ]
Elissondo, Natalia [3 ]
Gambino, Guillermo [3 ]
Celina Elissondo, Maria [1 ,2 ]
机构
[1] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Lab Zoonosis Parasitarias, Dept Biol, RA-7600 Mar Del Plata, Buenos Aires, Argentina
[2] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina
[3] Lab Anal Clin Santisteban, RA-7000 Buenos Aires, DF, Argentina
关键词
Echinocactus multilocularis; Alveolar echinococcosis; Albendazole; Thymol; Liver enzymes; ALVEOLAR ECHINOCOCCOSIS; ESSENTIAL OILS; VITRO; EFFICACY; PROTOSCOLECES; METACESTODES; SURVIVAL;
D O I
10.1016/j.vetpar.2015.06.030
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Human alveolar echinococcosis (AE) is caused by the fox tapeworm Echinococcus multilocularis and is usually lethal if left untreated. The current strategy for treating human AE is surgical resection of the parasite mass complemented by chemotherapy with benzimidazole compounds. However, reliable chemotherapeutic alternatives have not yet been developed stimulating the research of new treatment strategies such as the use of medicinal plants. The aim of the current study was to investigate the efficacy of the combination albendazole (ABZ) + thymol on mice infected with E. multilocularis metacestodes. For this purpose, mice infected with parasite material were treated daily for 20 days with ABZ (5 mg/kg), thymol (40 mg/kg) or ABZ (5 mg/kg) + thymol (40 mg/kg) or left untreated as controls. After mice were euthanixed, cysts were removed from the peritoneal cavity and the treatment efficacy was evaluated by the mean cysts weight, viability of protoscoleces and ultrastructural changes of cysts and protoscoleces. The application of thymol or the combination of ABZ+thymol resulted in a significant reduction of the cysts weight compared to untreated mice. We also found that although ABZ and thymol had a scolicidal effect, the combination of the two compounds had a considerably stronger effect showing a reduction in the protoscoleces viability of 62%. These results were also corroborated by optical microscopy, SEM and TEM. Protoscoleces recovered from ABZ or thymol treated mice showed alterations as contraction of the soma region, rostellar disorganization and presence of blebs in the tegument. However both drugs when combined lead to a total loss of the typical morphology of protoscoleces. All cysts removed from control mice appeared intact and no change in ultrastructure was detected. In contrast, cysts developed in mice treated with ABZ revealed changes in the germinal layer as reduction in cell number, while the treatment with thymol or the ABZ+ thymol combination predominantly showed presence of cell debris. On the other hand, no differences were found in alkaline phosphatase (AP), glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) activities between control and treated mice, indicating the lack of toxicity of the different drug treatments during the experiment. Because combined ABZ+ thymol treatment exhibited higher treatment efficiency compared with the drugs applied separately against murine experimental alveolar echinococcosis, we propose it would be a useful option for the treatment of human AE. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 50 条
  • [31] Development of a chemotherapeutic model for the in vitro screening of drugs against Echinococcus granulosus cysts: The effects of an albendazole albendazole sulphoxide combination
    Casado, N
    PerezSerrano, J
    Denegri, G
    RodriguezCaabeiro, F
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1996, 26 (01) : 59 - 65
  • [32] Efficacy of thymol against Echinococcus granulosus protoscoleces
    Elissondo, M. Celina
    Albani, Clara M.
    Gende, Liesel
    Eguaras, Martin
    Denegri, Guillermo
    PARASITOLOGY INTERNATIONAL, 2008, 57 (02) : 185 - 190
  • [33] Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Echinococcus multilocularis infections in cats
    Prullage, Joe
    Bowman, Dwight
    Ulrich, Michael
    Tielemans, Eric
    PARASITE, 2021, 28
  • [34] Echinococcus multilocularis massive pericardial infection:: Late and dramatic improvement under albendazole therapy
    Lidove, O
    Chauveheid, MP
    Papo, T
    Vuitton, DA
    Piarroux, R
    Hernigou, A
    Charlotte, F
    Piette, JC
    Penaud, D
    Scheublé, C
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (02): : 195 - 197
  • [35] Impact of Albendazole on Cytokine and Chemokine Response Profiles in Echinococcus multilocularis-Inoculated Mice
    Wu, Jing
    Ma, Hai-zhang
    Apaer, Shadike
    Anweier, Nuerzatijiang
    Zeng, Qi
    Fulati, Xiafukati
    Li, Tao
    Zhao, Jin-ming
    Wen, Hao
    Tuxun, Tuerhongjiang
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [36] Ubenimex combined with Albendazole for the treatment of Echinococcus multilocularis-induced alveolar echinococcosis in mice
    Zhou, Zhen
    Huayu, Meiduo
    Mu, Yalin
    Tang, Feng
    Ge, Ri-Li
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [37] Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis
    Lundstrom-Stadelmann, Britta
    Rufener, Reto
    Hemphill, Andrew
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2020, 13 : 121 - 129
  • [38] Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone
    Stettler, M
    Siles-Lucas, M
    Sarciron, E
    Lawton, P
    Gottstein, B
    Hemphill, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) : 2256 - 2262
  • [39] In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes
    Jura, H
    Bader, A
    Frosch, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1052 - 1056
  • [40] In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus
    Naguleswaran, Arunasalam
    Spicher, Martin
    Vonlaufen, Nathalie
    Ortega-Mora, Luis M.
    Torgerson, Paul
    Gottstein, Bruno
    Hemphill, Andrew
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3770 - 3778